Anna Marie Mulligan

19.9k total citations
56 papers, 1.8k citations indexed

About

Anna Marie Mulligan is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Anna Marie Mulligan has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 23 papers in Cancer Research. Recurrent topics in Anna Marie Mulligan's work include Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (13 papers) and HER2/EGFR in Cancer Research (9 papers). Anna Marie Mulligan is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (13 papers) and HER2/EGFR in Cancer Research (9 papers). Anna Marie Mulligan collaborates with scholars based in Canada, United States and Ireland. Anna Marie Mulligan's co-authors include Frances P. O’Malley, Irene L. Andrulis, Dushanthi Pinnaduwage, Shelley B. Bull, Michael Reedijk, Hui Zhang, Brendan C. Dickson, Sean E. Egan, Linda Feeley and Blaise Clarke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Anna Marie Mulligan

55 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Marie Mulligan Canada	25	879	715	579	518	233	56	1.8k
Rie Horii Japan	24	763 0.9×	927 1.3×	298 0.5×	650 1.3×	253 1.1×	100	1.7k
Tomohiko Aihara Japan	23	721 0.8×	772 1.1×	715 1.2×	579 1.1×	284 1.2×	67	2.0k
Marie‐Christine Mathieu France	25	978 1.1×	705 1.0×	461 0.8×	445 0.9×	403 1.7×	63	2.1k
Erika Resetkova United States	24	712 0.8×	731 1.0×	378 0.7×	684 1.3×	467 2.0×	86	2.0k
Sophia K. Apple United States	23	781 0.9×	609 0.9×	292 0.5×	470 0.9×	210 0.9×	72	1.6k
Masataka Yoshimoto Japan	26	810 0.9×	734 1.0×	630 1.1×	518 1.0×	258 1.1×	84	1.8k
F P O’Malley Canada	16	1.0k 1.2×	911 1.3×	594 1.0×	526 1.0×	278 1.2×	27	2.0k
Giuseppe Cancello Italy	24	1.5k 1.7×	1.1k 1.6×	316 0.5×	391 0.8×	435 1.9×	44	2.0k
Wendy Recant United States	23	972 1.1×	559 0.8×	764 1.3×	502 1.0×	485 2.1×	47	2.4k
V J Bardou France	18	1.2k 1.3×	821 1.1×	553 1.0×	590 1.1×	371 1.6×	32	2.2k

Countries citing papers authored by Anna Marie Mulligan

Since Specialization

Citations

This map shows the geographic impact of Anna Marie Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Marie Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Marie Mulligan more than expected).

Fields of papers citing papers by Anna Marie Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Marie Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Marie Mulligan. The network helps show where Anna Marie Mulligan may publish in the future.

Co-authorship network of co-authors of Anna Marie Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Marie Mulligan. A scholar is included among the top collaborators of Anna Marie Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Marie Mulligan. Anna Marie Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mulligan, Anna Marie, et al.. (2025). Seven-month persistence of COVID-19 vaccine-induced lymphadenopathy: a case report. Journal of Medical Case Reports. 19(1). 143–143.

Nielsen, Torsten O., Samuel Leung, Nazia Riaz, et al.. (2023). Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. Histopathology. 83(6). 903–911. 3 indexed citations

Lim, David W., et al.. (2023). Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgical Oncology. 30(7). 4123–4131. 3 indexed citations

Menes, Tehillah S., Anabel M. Scaranelo, Rachel Fleming, et al.. (2021). The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI. Breast Cancer Research and Treatment. 190(2). 317–327. 1 indexed citations

Swain, Monali, Manjula Maganti, Tulin Cil, et al.. (2020). Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation. International Journal of Radiation Oncology*Biology*Physics. 108(3). 676–685. 13 indexed citations

Pezo, Rossanna C., Tom Wei‐Wu Chen, Hal K. Berman, et al.. (2017). Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. Breast Cancer Research and Treatment. 168(1). 159–168. 22 indexed citations

Angarita, Fernando A., Tyler R. Chesney, Christine Elser, et al.. (2015). Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. European Journal of Surgical Oncology. 41(5). 625–634. 35 indexed citations

Mulligan, Anna Marie, Dushanthi Pinnaduwage, Sandrine Tchatchou, Shelley B. Bull, & Irene L. Andrulis. (2015). Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer. Cancer Immunology Research. 4(1). 41–48. 24 indexed citations

Agarwal, Seema, Dushanthi Pinnaduwage, Frank B. Gertler, et al.. (2015). Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. BMC Cancer. 15(1). 483–483. 29 indexed citations

10.

El‐Bahrawy, Mona, Steve E. Kalloger, Najla Aldaoud, et al.. (2014). Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas. International Journal of Gynecological Pathology. 33(6). 560–567. 17 indexed citations

11.

Lesurf, Robert, Hong Zhao, Dushanthi Pinnaduwage, et al.. (2013). Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proceedings of the National Academy of Sciences. 110(14). E1301–10. 54 indexed citations

12.

Mulligan, Anna Marie, Irene Raitman, Linda Feeley, et al.. (2012). Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry. Clinical Cancer Research. 19(2). 336–346. 116 indexed citations

13.

Hanna, Wedad, Penny J. Barnes, Richard Berendt, et al.. (2012). Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada. Current Oncology. 19(6). 315–323. 10 indexed citations

14.

Kalloger, Steve E., Ghassan Allo, Anna Marie Mulligan, et al.. (2012). Use of Mismatch Repair Immunohistochemistry and Microsatellite Instability Testing. The American Journal of Surgical Pathology. 36(4). 560–569. 19 indexed citations

15.

Mulligan, Anna Marie, Dushanthi Pinnaduwage, Anita Bane, et al.. (2010). CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry. Cancer. 117(7). 1350–1359. 12 indexed citations

16.

Broom, Reuben, Patricia A. Tang, Christine Simmons, et al.. (2009). Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.. PubMed. 29(5). 1557–62. 120 indexed citations

17.

Reedijk, Michael, Dushanthi Pinnaduwage, Brendan C. Dickson, et al.. (2007). JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Research and Treatment. 111(3). 439–448. 119 indexed citations

18.

Mulligan, Anna Marie, et al.. (2007). PGDS, A Novel Technique Combining Chromogenic In Situ Hybridization and Immunohistochemistry for the Assessment of ErbB2 (HER2/neu) Status in Breast Cancer. Applied immunohistochemistry & molecular morphology. 15(3). 316–324. 16 indexed citations

19.

Scaranelo, Anabel M., Karina Bukhanov, Pavel Crystal, Anna Marie Mulligan, & F P O’Malley. (2007). Granular cell tumour of the breast: MRI findings and review of the literature. British Journal of Radiology. 80(960). 970–974. 43 indexed citations

20.

Mulligan, Anna Marie, et al.. (2004). Sclerosing Polycystic Sialadenopathy. Archives of Otolaryngology - Head and Neck Surgery. 130(3). 357–357. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact